These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 34978092)

  • 1. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
    Fukushima T; Umino M; Sakamoto T; Onozato M
    Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the kynurenine pathway in human glioma pathophysiology.
    Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
    PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
    Badawy AA
    Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome.
    Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma.
    Arnhard K; Pitterl F; Sperner-Unterweger B; Fuchs D; Koal T; Oberacher H
    Electrophoresis; 2018 May; 39(9-10):1171-1180. PubMed ID: 29327354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
    Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
    Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
    Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
    Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
    Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kynurenine and its metabolites in nervous system diseases].
    Vécsei L; Schwab F
    Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
    Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
    J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Naritsin DB; Saito K; Markey SP; Chen CY; Heyes MP
    J Neurochem; 1995 Nov; 65(5):2217-26. PubMed ID: 7595510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of tryptophan metabolites with the type and severity of multiple sclerosis.
    Isık SMT; Onmaz DE; Ekmekci AH; Ozturk S; Unlu A; Abusoglu S
    Mult Scler Relat Disord; 2023 Sep; 77():104898. PubMed ID: 37481818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
    Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
    Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.